126 related articles for article (PubMed ID: 37958481)
1. Correction: Brosch et al. Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration.
Brosch PK; Korsa T; Taban D; Eiring P; Kreisz P; Hildebrand S; Neubauer J; Zimmermann H; Sauer M; Shirakashi R; Djuzenova CS; Sisario D; Sukhorukov VL
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958481
[TBL] [Abstract][Full Text] [Related]
2. Glucose and Inositol Transporters, SLC5A1 and SLC5A3, in Glioblastoma Cell Migration.
Brosch PK; Korsa T; Taban D; Eiring P; Hildebrand S; Neubauer J; Zimmermann H; Sauer M; Shirakashi R; Djuzenova CS; Sisario D; Sukhorukov VL
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497276
[TBL] [Abstract][Full Text] [Related]
3. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth.
Cui Z; Mu C; Wu Z; Pan S; Cheng Z; Zhang ZQ; Zhao J; Xu C
Cell Death Dis; 2022 Jun; 13(6):569. PubMed ID: 35760803
[TBL] [Abstract][Full Text] [Related]
4. SLC5A3 is important for cervical cancer cell growth.
Li L; Shen FR; Cheng Q; Sun J; Li H; Sun HT; Cai X; Chen M; Yang B; Wang L; Xu L
Int J Biol Sci; 2023; 19(9):2787-2802. PubMed ID: 37324953
[TBL] [Abstract][Full Text] [Related]
5. Hypotonic activation of the myo-inositol transporter SLC5A3 in HEK293 cells probed by cell volumetry, confocal and super-resolution microscopy.
Andronic J; Shirakashi R; Pickel SU; Westerling KM; Klein T; Holm T; Sauer M; Sukhorukov VL
PLoS One; 2015; 10(3):e0119990. PubMed ID: 25756525
[TBL] [Abstract][Full Text] [Related]
6. Myo-Inositol Transporter SLC5A3 Associates with Degenerative Changes and Inflammation in Sporadic Inclusion Body Myositis.
De Paepe B; Merckx C; Jarošová J; Cannizzaro M; De Bleecker JL
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32235474
[TBL] [Abstract][Full Text] [Related]
7. Response to Brosch et al.
Pihlajamäki J; Lerin C; Kaminska D; Venesmaa S; Itkonen P; Boes T; Floss T; Schroeder J; Dearie F; Crunkhorn S; Burak F; Jimenez-Chillaron JC; Kuulasmaa T; Miettinen P; Park PJ; Nasser I; Zhao Z; Zhang Z; Xu Y; Wurst W; Ren H; Morris AJ; Stamm S; Goldfine AB; Laakso M; Patti ME
Cell Metab; 2012 Mar; 15(3):267-269. PubMed ID: 25960695
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the null murine sodium/myo-inositol cotransporter 1 (Smit1 or Slc5a3) phenotype: myo-inositol rescue is independent of expression of its cognate mitochondrial ribosomal protein subunit 6 (Mrps6) gene and of phosphatidylinositol levels in neonatal brain.
Buccafusca R; Venditti CP; Kenyon LC; Johanson RA; Van Bockstaele E; Ren J; Pagliardini S; Minarcik J; Golden JA; Coady MJ; Greer JJ; Berry GT
Mol Genet Metab; 2008; 95(1-2):81-95. PubMed ID: 18675571
[TBL] [Abstract][Full Text] [Related]
9. SLC5A3-Dependent Myo-inositol Auxotrophy in Acute Myeloid Leukemia.
Wei Y; Huang YH; Skopelitis DS; Iyer SV; Costa ASH; Yang Z; Kramer M; Adelman ER; Klingbeil O; Demerdash OE; Polyanskaya SA; Chang K; Goodwin S; Hodges E; McCombie WR; Figueroa ME; Vakoc CR
Cancer Discov; 2022 Feb; 12(2):450-467. PubMed ID: 34531253
[TBL] [Abstract][Full Text] [Related]
10. The human osmoregulatory Na+/myo-inositol cotransporter gene (SLC5A3): molecular cloning and localization to chromosome 21.
Berry GT; Mallee JJ; Kwon HM; Rim JS; Mulla WR; Muenke M; Spinner NB
Genomics; 1995 Jan; 25(2):507-13. PubMed ID: 7789985
[TBL] [Abstract][Full Text] [Related]
11. Select nutrients in the ovine uterine lumen. ii. glucose transporters in the uterus and peri-implantation conceptuses.
Gao H; Wu G; Spencer TE; Johnson GA; Bazer FW
Biol Reprod; 2009 Jan; 80(1):94-104. PubMed ID: 18753604
[TBL] [Abstract][Full Text] [Related]
12. Increased trophoblast expression of NFAT5/TonEBP in pre-eclamptic placentas and hyperosmolar-treated BeWo cells.
Lee GT; Price MD; Mejia CA; Galan HL; Arroyo JA
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():37-43. PubMed ID: 25461350
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the expression and regulation of genes necessary for myo-inositol biosynthesis and transport in the seminiferous epithelium.
Chauvin TR; Griswold MD
Biol Reprod; 2004 Mar; 70(3):744-51. PubMed ID: 14613899
[TBL] [Abstract][Full Text] [Related]
14. Correction: Gresseau et al. A Signaling Crosstalk Links SNAIL to the 37/67 kDa Laminin-1 Receptor Ribosomal Protein SA and Regulates the Acquisition of a Cancer Stem Cell Molecular Signature in U87 Glioblastoma Neurospheres.
Gresseau L; Roy ME; Duhamel S; Annabi B
Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473439
[TBL] [Abstract][Full Text] [Related]
15. Murine chromosome 16 telomeric region, homologous with human chromosome 21q22, contains the osmoregulatory Na(+)/myo-inositol cotransporter (SLC5A3) gene.
McVeigh KE; Mallee JJ; Lucente A; Barnoski BL; Wu S; Berry GT
Cytogenet Cell Genet; 2000; 88(1-2):153-8. PubMed ID: 10773690
[TBL] [Abstract][Full Text] [Related]
16. SLC5A1 promotes growth and proliferation of pancreatic carcinoma via glucose-dependent AMPK/mTOR signaling.
Gao HF; Chen LY; Cheng CS; Chen H; Meng ZQ; Chen Z
Cancer Manag Res; 2019; 11():3171-3185. PubMed ID: 31114359
[No Abstract] [Full Text] [Related]
17. Correction: Godugu et al. Anti-Cancer Activities of Thyrointegrin α
Godugu K; Rajabi M; Mousa SA
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358892
[TBL] [Abstract][Full Text] [Related]
18. The 21q22.1 STS marker, VN02 (EST00541 cDNA), is part of the 3' sequence of the human Na+/myo-inositol cotransporter (SLC5A3) gene.
Berry GT; Mallee JJ; Blouin JL; Antonarakis SE
Cytogenet Cell Genet; 1996; 73(1-2):77-8. PubMed ID: 8646889
[TBL] [Abstract][Full Text] [Related]
19. Correction: Mathew et al. Metabolic Signature of Warburg Effect in Cancer: An Effective and Obligatory Interplay between Nutrient Transporters and Catabolic/Anabolic Pathways to Promote Tumor Growth.
Mathew M; Nguyen NT; Bhutia YD; Sivaprakasam S; Ganapathy V
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730740
[TBL] [Abstract][Full Text] [Related]
20. Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
Liau LM; Ashkan K; Tran DD; Campian JL; Trusheim JE; Cobbs CS; Heth JA; Salacz M; Taylor S; D'Andre SD; Iwamoto FM; Dropcho EJ; Moshel YA; Walter KA; Pillainayagam CP; Aiken R; Chaudhary R; Goldlust SA; Bota DA; Duic P; Grewal J; Elinzano H; Toms SA; Lillehei KO; Mikkelsen T; Walbert T; Abram SR; Brenner AJ; Brem S; Ewend MG; Khagi S; Portnow J; Kim LJ; Loudon WG; Thompson RC; Avigan DE; Fink KL; Geoffroy FJ; Lindhorst S; Lutzky J; Sloan AE; Schackert G; Krex D; Meisel HJ; Wu J; Davis RP; Duma C; Etame AB; Mathieu D; Kesari S; Piccioni D; Westphal M; Baskin DS; New PZ; Lacroix M; May SA; Pluard TJ; Tse V; Green RM; Villano JL; Pearlman M; Petrecca K; Schulder M; Taylor LP; Maida AE; Prins RM; Cloughesy TF; Mulholland P; Bosch ML
J Transl Med; 2018 Jun; 16(1):179. PubMed ID: 29958537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
